viernes, 7 de diciembre de 2018

FAAH inhibition for treatment of problematic cannabis use - The Lancet Psychiatry

FAAH inhibition for treatment of problematic cannabis use - The Lancet Psychiatry

Morning Rounds

Megan Thielking



Could an experimental drug treat cannabis use disorder?

New results from a randomized trial suggest that an experimental drug might help ease withdrawal symptoms in men with cannabis use disorder — but experts caution more research is needed. People with cannabis use disorder can experience cravings, withdrawal, and other issues. In a study of 70 men, those who received the drug had fewer withdrawal symptoms and used less marijuana after four weeks than men on a placebo. In a commentary tied to the study, University of Toronto's Dr. Tony George noted the study seemed to exclude adults with psychiatric conditions and didn’t look at functional impairments. George said the drug needs to be studied in more patients over more time.

No hay comentarios: